This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: Journals

New SSC Recommendations and Guidelines Released by JTH

Tuesday, September 29, 2015   (0 Comments)
Posted by: Luke Blount
Share |

The Journal of Thrombosis and Haemostasis (JTH) has accepted the following articles on recommendations from the Scientific and Standardization Committee (SSC) Subcommittees of the ISTH: 

Subcommittee on the Control of Anticoagulation: Assessment of effectiveness of major bleeding management; Proposed definitions for effective hemostasis
A broad spectrum of definitions for the clinical effectiveness of management given for bleeding events related to anticoagulants have been used in published clinical studies [1-3]. This diversity hampers any attempt to compare the different trials and to perform meta-analyses [4]. Yet, without doubt, clinical outcome in the form of hemostatic efficacy is the most important parameter for evaluating the effectiveness of a given therapy. Read more.

Subcommittee on the Control of Anticoagulation: Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients
The term clinically relevant non-major bleeding (CRNMB) has recently been incorporated into the outcomes of atrial fibrillation (AF) and venous thromboembolic (VTE) disease clinical trials to further define a bleeding event that is neither a major bleed as defined by the International Society on Thrombosis and Haemostasis (ISTH), nor a non-clinically consequential minor bleeding event. This relatively new term for anticoagulant related bleeding suffers the same lack of harmonization as major bleeding did a decade ago. Read more.


Membership Management Software Powered by YourMembership  ::  Legal